Celldex Therapeutics (CLDX) is scheduled to report Q1 earnings on May 7, 2026. Analysts estimate EPS of $-1.12 and quarterly revenue of $1.04M.

In the most recent quarter (Q4), Celldex Therapeutics reported EPS of $-1.22, missing estimates of $-1.00 by 0.22%. Revenue came in at $100.00K, missing the estimate of $1.45M by 0.93%.

Celldex Therapeutics has missed EPS estimates in 2 consecutive quarters.

Over the last 4 quarters, Celldex Therapeutics has averaged an EPS surprise of 0.11% and a revenue surprise of 0.69%.